FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1984832017> ?p ?o ?g. }

• W1984832017 abstract "Although small cell lung cancer (SCLC) remains largely incurable, considerable progress has been made over the past 20 years in the development of combination chemotherapy regimens that significantly improve patient survival and quality of life. Several platinum plus etoposide regimens used alone, concomitantly with radiotherapy in limited-stage SCLC, or alternating with cyclophosphamide, doxorubicin, and vincristine are currently considered the treatments of choice for most patients. However, several other regimens of equal or nearly equal efficacy can be used, especially when patient occupation or other medical conditions, such as congestive heart failure, arrythmias, renal dysfunction, arthritis or pre-existing peripheral neuropathy, or hearing loss, require avoidance of cisplatin, doxorubicin, or vincristine. Although high-dose chemotherapy regimens aimed at exploiting an apparent dose-intensity-response relationship continue to be of interest, no data justify their routine use outside of a controlled clinical trial setting. Hematopoietic colony stimulating factors have been shown to reduce infectious complications, allow the maintenance of dose rates, and offer the potential that dose-intensive regimens might be investigated more safely. However, their high cost, the question of whether maintenance or intensification of dose rates is useful, and a report of an adverse radiation therapy interaction with granulocyte-macrophage colony-stimulating factor indicate that additional studies are needed to better define the role of this interesting class of agents in the treatment of this disease. Continued advances in autologous bone marrow transplantation technology that will allow safe administration of dose-intensive chemotherapy regimens, in the development of potent new microtubule and topoisomerse inhibitors (taxanes and camptothecins), and in identification of novel biological and molecular targets (autocrine growth factor loops and suppressor genes) hold great promise for significant improvements in the treatment of SCLC in the near future." @default.
• W1984832017 created "2016-06-24" @default.
• W1984832017 creator A5084295219 @default.
• W1984832017 date "1995-01-01" @default.
• W1984832017 modified "2023-09-27" @default.
• W1984832017 title "Chemotherapy in small cell lung cancer: The current state of the art" @default.
• W1984832017 cites W149878195 @default.
• W1984832017 cites W175059980 @default.
• W1984832017 cites W1807610754 @default.
• W1984832017 cites W1865574899 @default.
• W1984832017 cites W1868305875 @default.
• W1984832017 cites W1876684013 @default.
• W1984832017 cites W1884032213 @default.
• W1984832017 cites W1885320430 @default.
• W1984832017 cites W1894342532 @default.
• W1984832017 cites W1934533231 @default.
• W1984832017 cites W1935482218 @default.
• W1984832017 cites W1952431753 @default.
• W1984832017 cites W1960463703 @default.
• W1984832017 cites W1961129053 @default.
• W1984832017 cites W1961171505 @default.
• W1984832017 cites W1976230131 @default.
• W1984832017 cites W1979118010 @default.
• W1984832017 cites W1982172413 @default.
• W1984832017 cites W1987251988 @default.
• W1984832017 cites W2010426855 @default.
• W1984832017 cites W2012581798 @default.
• W1984832017 cites W2017416417 @default.
• W1984832017 cites W2027904797 @default.
• W1984832017 cites W2051334096 @default.
• W1984832017 cites W2057336215 @default.
• W1984832017 cites W2065842445 @default.
• W1984832017 cites W2077003696 @default.
• W1984832017 cites W2085026102 @default.
• W1984832017 cites W2088766047 @default.
• W1984832017 cites W2097597328 @default.
• W1984832017 cites W2111087867 @default.
• W1984832017 cites W2123767004 @default.
• W1984832017 cites W2127061702 @default.
• W1984832017 cites W2138917119 @default.
• W1984832017 cites W2148865542 @default.
• W1984832017 cites W2172820356 @default.
• W1984832017 cites W2174776393 @default.
• W1984832017 cites W2230155084 @default.
• W1984832017 cites W2233083084 @default.
• W1984832017 cites W2247198812 @default.
• W1984832017 cites W2253767836 @default.
• W1984832017 cites W2275719061 @default.
• W1984832017 cites W2337660074 @default.
• W1984832017 cites W2341557816 @default.
• W1984832017 cites W2341745217 @default.
• W1984832017 cites W2395047439 @default.
• W1984832017 cites W2401419465 @default.
• W1984832017 cites W2402495904 @default.
• W1984832017 cites W2405738268 @default.
• W1984832017 cites W2411674742 @default.
• W1984832017 cites W2415522930 @default.
• W1984832017 cites W2418513986 @default.
• W1984832017 cites W2423635603 @default.
• W1984832017 cites W2470358897 @default.
• W1984832017 cites W2585552927 @default.
• W1984832017 cites W2897286732 @default.
• W1984832017 cites W587216881 @default.
• W1984832017 cites W68859659 @default.
• W1984832017 cites W850470413 @default.
• W1984832017 doi "https://doi.org/10.1016/s1053-4296(05)80007-4" @default.
• W1984832017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10717123" @default.
• W1984832017 hasPublicationYear "1995" @default.
• W1984832017 type Work @default.
• W1984832017 sameAs 1984832017 @default.
• W1984832017 citedByCount "6" @default.
• W1984832017 crossrefType "journal-article" @default.
• W1984832017 hasAuthorship W1984832017A5084295219 @default.
• W1984832017 hasConcept C126322002 @default.
• W1984832017 hasConcept C141071460 @default.
• W1984832017 hasConcept C143998085 @default.
• W1984832017 hasConcept C177713679 @default.
• W1984832017 hasConcept C2776694085 @default.
• W1984832017 hasConcept C2776755627 @default.
• W1984832017 hasConcept C2778119113 @default.
• W1984832017 hasConcept C2779429289 @default.
• W1984832017 hasConcept C71924100 @default.
• W1984832017 hasConceptScore W1984832017C126322002 @default.
• W1984832017 hasConceptScore W1984832017C141071460 @default.
• W1984832017 hasConceptScore W1984832017C143998085 @default.
• W1984832017 hasConceptScore W1984832017C177713679 @default.
• W1984832017 hasConceptScore W1984832017C2776694085 @default.
• W1984832017 hasConceptScore W1984832017C2776755627 @default.
• W1984832017 hasConceptScore W1984832017C2778119113 @default.
• W1984832017 hasConceptScore W1984832017C2779429289 @default.
• W1984832017 hasConceptScore W1984832017C71924100 @default.
• W1984832017 hasLocation W19848320171 @default.
• W1984832017 hasLocation W19848320172 @default.
• W1984832017 hasOpenAccess W1984832017 @default.
• W1984832017 hasPrimaryLocation W19848320171 @default.
• W1984832017 isParatext "false" @default.
• W1984832017 isRetracted "false" @default.
• W1984832017 magId "1984832017" @default.
• W1984832017 workType "article" @default.